Moreover, SETD7 interacts with p53, ERα, TAF7, and YAP1 and regulates oncogenic pathways such as Wnt/ß-catenin and Hippo-pathway, contributing to numerous biological processes, including tumor immune microenvironment [40]. The gene discussed is TP53; the disease is neoplasm.